UPDATE: Goldman Sachs Downgrades Phathom Pharmaceuticals (PHAT) to Sell
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- S&P 500 futures steady after midterm rally; Nasdaq lags on chip weakness
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: PHAT) | Delayed: 5.68 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.68 | 52 Week High | $ | |||
| Open | $5.68 | 52 Week Low | $ | |||
| Day High | $5.68 | P/E | N/A | |||
| Day Low | $5.68 | EPS | $ | |||
| Volume | 18 | |||||
